Safety, Tolerability, Pharmacokinetics (PK) of the Anti-Orthopox Drug, ST-246

Clinical trial NCT00907803 · COMPLETED

Trial details

NCT number: NCT00907803
Sponsor: SIGA Technologies
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Orthopoxviral Disease

Start date: 2009-06-01
Primary completion: 2010-01-01
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.